What is Acid Reflux

SCOTTS VALLEY — The Gillin family of Scotts Valley is holding their breath, and praying, that tests done on Feb.

Jan. 30 (Bloomberg) — Takeda Pharmaceutical Co. won U.S. approval to sell a new version of the acid-reflux treatment Prevacid, the Japanese drugmaker’s second-biggest medicine.

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved KAPIDEX(TM) delayed release capsules for the once-daily, oral treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease, the healing of erosive esophagitis and the maintenance …

Drug stock investors are getting optimistic, but the technical picture still stinks. Buy some puts.

If you’re looking for that safe haven in which to stash your cash away from the volatile ups and downs that continue to plague the market, I would steer clear of the pharmaceutical sector…( Read More )

Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a new tablet formulation to add to its ZEGERID® family of branded prescription pharmaceutical products.

A new procedure can help acid reflux sufferers without invasive surgery. Acid reflux is a disease that affects millions of Americans. It’s a very painful condition that can be caused by the consumption of certain foods.

Submitted by WWAY on 30 January 2009 – 11:02am. READ MORE: A study tracking thousands of heart patients finds those who were taking certain acid reflux medications, along with the blood thinning drug PLAVIX, were more likely to suffer a second heart attack.

Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a new tablet formulation to add to its ZEGERID® family of branded prescription pharmaceutical products. The new formulation is an immediate-release tablet that combines omeprazole, a proton pump inhibitor (PPI), with a mix of buffers.

Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a new tablet formulation to add to its ZEGERID® family of branded prescription pharmaceutical products. The new formulation is an immediate-release tablet that combines omeprazole, a proton pump inhibitor (PPI), with a mix of buffers.

Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a new tablet formulation to add to its ZEGERID® family of branded prescription pharmaceutical products. The new formulation is an immediate-release tablet that combines omeprazole, a proton pump inhibitor (PPI), with a mix of buffers.

Right Now Registration of township children for winter story time sessions at the Rockaway Township Free Public Library at 61 Mount Hope Road and at the Hibernia Branch on Green Pond Road is now underway. The winter sessions runs through March 13. Come into the library for a complete schedule or go to www.rtlibrary.org and click on Kids’ Programs.

Right Now Registration of township children for winter story time sessions at the Rockaway Township Free Public Library at 61 Mount Hope Road and at the Hibernia Branch on Green Pond Road is now underway. The winter sessions runs through March 13. Come into the library for a complete schedule or go to www.rtlibrary.org and click on Kids’ Programs.

Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a new tablet formulation to add to its ZEGERID ® family of branded prescription pharmaceutical products. The new formulation is an immediate-release tablet that combines omeprazole, a proton pump inhibitor (PPI), …

30 January 2009 DUBAI – Bad eating and sleeping habits that are partly attributed to traffic snarls have led to a rise in a lesser-known abdominal disease which is increasingly affecting the quality of people’s lives in the UAE.

Taking the widely prescribed blood thinner after a heart attack with common acid-reflux drugs could increase chances of another heart attack, says study

Right Now Registration of township children for winter story time sessions at the Rockaway Township Free Public Library at 61 Mount Hope Road and at the Hibernia Branch on Green Pond Road is now underway. The winter sessions runs through March 13. Come into the library for a complete schedule or go to www.rtlibrary.org and click on Kids’ Programs.

Senior citizen Louisette Lipstadt of Conway, N.H., needed a prescription that cost more than $200 a month. “That’s a lot of money. I can’t afford it,” said Lipstadt, who receives Social Security.

Patients taking both a popular blood-thinning drug and anti-acid medications may actually boost their risk of having a heart attack, a new study suggests.

By D.x. Ferris More than four years after its last release, Keelhaul has a new record ready, with its fourth album, Triumphant Return to Obscurity, slated for mid-spring release. Avant-metal indie label Hydra Head, home of underground godheads like Jesu, Pelican and Torche, as well as Keelhaul’s last two albums, will issue the LP. “It sounds great,” says drummer Will Scharf. “Our drummer …